4519 On Other Exchanges
Symbol
Exchange
4519 is not on other exchanges.

Executive Profile*

Osamu Nagayama

Chairman & Chief Executive Officer,Chugai Pharmaceutical Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 52 board members in 4 different organizations across 4 different industries.

See Board Relationships
70--
As of Fiscal Year 2016

Background*

Mr. Osamu Nagayama has been the Chief Executive Officer of Chugai Pharmaceutical Co. Ltd. since 1992. Mr. Nagayama served as the President and Chief Operating Officer of Chugai Pharmaceutical Co. Ltd. until February 2012. He has been with Chugai Pharmaceutical Co. Ltd. since 1978. He served as a Director of Pharmaceutical Sales & Marketing Division and International Business Division of Chugai since 1983, Deputy General Manager of Pharmaceutical Research and Development ...

Read Full Background

Corporate Headquarters*

Nihonbashi Mitsui Tower
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships*

Director and Chairman of the Board of Directors of Sony Corporation
1989-Present
Chairman & Chief Executive Officer
2010-Present
Chairman

Education*

Unknown/Other Education
Keio University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman and Chief Executive Officer
Amgen Inc.
$1.5M
Ian C. Read Chairman and Chief Executive Officer
Pfizer Inc.
$1.9M
Jeffrey R. Immelt Executive Chairman & CEO
General Electric Company
$8.1M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co., Inc.
$1.5M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
SFr.4.9M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.